
Association Between Use of β-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
Keywords: ASA; β-Adrenergic receptor antagonist; β-Blocker; Epidemiology; High-risk prostate cancer; Metastasis; Norway; Prostate cancer; Prostate cancer-specific mortality; Statin;